|
|
Circovirus vaccine receives four-month duration of immunity approval Boehringer Ingelheim Vetmedica, Inc., (BIVI), St. Joseph, Mo., announces the U.S. Animal and Plant Health Inspection Service has approved a duration of immunity (DOI) claim for Ingelvac CircoFLEX of at least four months for porcine circovirus type 2 (PCV2), the primary pathogen for porcine circovirus associated disease (PCVAD). According to Klaas Okkinga, marketing manager for Boehringer Ingelheim, the approved DOI label extension substantiates extensive research findings that Ingelvac CircoFLEX provides long-lasting protection from PCV2. "A vaccine that provides at least four months of PCV2 immunity is a significant benefit to producers in protecting pigs, both early and late, from damage caused by this disease," says Okkinga. "Currently, Ingelvac CircoFLEX is the only PCV2 vaccine available with proven DOI of this length when administered as a single-dose to pigs 3 weeks of age or older," Okkinga adds. "Even when administered early, it still protects through the critical period in grow-finish, resulting in reduced pig mortality and improved performance." For more information, call 800-325-9167, or visit www.bi-vetmedica.com. 12/10/07 Date: 12/7/07
Copyright/Privacy
Copyright 1995-2008. High Plains Publishers, Inc. All rights reserved. Any republishing of these pages, including electronic reproduction of the editorial archives or classified advertising, is strictly prohibited. If you have questions or comments you can reach us at High Plains Journal 1500 E. Wyatt Earp Blvd., P.O. Box 760, Dodge City, KS 67801 or call 1-800-452-7171. Email: webmaster@hpj.com |
| ||||||||||||||||||||||
